Aberdeen Group
DFTX

Aberdeen Group’s Definium Therapeutics DFTX Stock Holding History

Aberdeen Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.23M Buy
+175,000
New +$4.32M 0.01% 634

Other funds holding DFTX

AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Aberdeen Group's DFTX Position: Q2 2026 in Review

Aberdeen Group opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 175,000 shares worth $8.23M. The stake represents 0.01% of the portfolio and ranks #634 among its holdings.

74 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Aberdeen Group held 175,000 shares of Definium Therapeutics worth $8.23M as of Q2 2026.
  • Definium Therapeutics was a new Aberdeen Group position in Q2 2026.
  • Definium Therapeutics made up 0.01% of Aberdeen Group's portfolio in Q2 2026, its #634 holding.
  • 74 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.